Literature DB >> 18778363

Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections.

M M Gaida1, F Günther, C Wagner, H Friess, N A Giese, J Schmidt, G M Hänsch, M N Wente.   

Abstract

The chemokine receptor CXCR6 has been described on lymphoid cells and is thought to participate in the homing of activated T-cells to non-lymphoid tissue. We now provide evidence that the chemokine receptor CXCR6 is also expressed by activated polymorphonuclear neutrophils (PMN) in vivo: Examination of biopsies derived from patients with pancreatic carcinoma by confocal laser scan microscopy revealed a massive infiltration of PMN that expressed CXCR6, while PMN of the peripheral blood of these patients did not. To answer the question whether CXCR6 expression is a property of infiltrated and activated PMN, leucocytes were collected from patients with localized soft tissue infections in the course of the wound debridement. By cytofluorometry, the majority of these cells were identified as PMN. Up to 50% of these PMN were also positive for CXCR6. Again, PMN from the peripheral blood of these patients were nearly negative for CXCR6, as were PMN of healthy donors. In a series of in vitro experiments, up-regulation of CXCR6 on PMN of healthy donors by a variety of cytokines was tested. So far, a minor, although reproducible, effect of tumour necrosis factor (TNFalpha) was seen: brief exposure with low-dose TNFalpha induced expression of CXCR6 on the surface of PMN. Furthermore, we could show an increased migration of PMN induced by the axis CXCL16 and CXCR6. In summary, our data provide evidence that CXCR6 is not constitutively expressed on PMN, but is up-regulated under inflammatory conditions and mediates migration of CXCR6-positive PMN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778363      PMCID: PMC2612713          DOI: 10.1111/j.1365-2249.2008.03745.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

Review 1.  Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking.

Authors:  Alex C Chin; Charles A Parkos
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

Review 2.  The many roles of chemokines and chemokine receptors in inflammation.

Authors:  Israel F Charo; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

Review 3.  Cancer immunoediting from immune surveillance to immune escape.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe
Journal:  Immunology       Date:  2007-03-26       Impact factor: 7.397

Review 4.  Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions.

Authors:  Curzio Rüegg
Journal:  J Leukoc Biol       Date:  2006-07-18       Impact factor: 4.962

5.  Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation.

Authors:  Sandra Mara A Arraes; Marta S Freitas; Simone V da Silva; Heitor A de Paula Neto; Jose Carlos Alves-Filho; Maria Auxiliadora Martins; Anibal Basile-Filho; Beatriz M Tavares-Murta; Christina Barja-Fidalgo; Fernando Q Cunha
Journal:  Blood       Date:  2006-07-18       Impact factor: 22.113

6.  CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.

Authors:  Yi Lu; Jianhua Wang; Yang Xu; Alisa E Koch; Zhong Cai; Xue Chen; Deborah L Galson; Russell S Taichman; Jian Zhang
Journal:  Mol Cancer Res       Date:  2008-03-14       Impact factor: 5.852

7.  Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis.

Authors:  Gabriela E Garcia; Luan D Truong; Ping Li; Ping Zhang; Richard J Johnson; Curtis B Wilson; Lili Feng
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 8.  Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.

Authors:  Keiichi Koizumi; Shozo Hojo; Takuya Akashi; Kazuo Yasumoto; Ikuo Saiki
Journal:  Cancer Sci       Date:  2007-11       Impact factor: 6.716

9.  CXCL14 expression and potential function in pancreatic cancer.

Authors:  Moritz N Wente; Christine Mayer; Matthias M Gaida; Christoph W Michalski; Thomas Giese; Frank Bergmann; Nathalia A Giese; Markus W Büchler; Helmut Friess
Journal:  Cancer Lett       Date:  2007-11-28       Impact factor: 8.679

10.  Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer.

Authors:  H Kayed; X Jiang; S Keleg; R Jesnowski; T Giese; M R Berger; I Esposito; M Löhr; H Friess; J Kleeff
Journal:  Br J Cancer       Date:  2007-09-18       Impact factor: 7.640

View more
  19 in total

1.  Expression and function of CXCL16 in a novel model of gout.

Authors:  Jeffrey H Ruth; Monica D Arendt; M Asif Amin; Salahuddin Ahmed; Hubert Marotte; Bradley J Rabquer; Charles Lesch; Solhee Lee; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2010-08

2.  Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration.

Authors:  Liping Zhang; Limei Ran; Gabriela E Garcia; Xiaonan H Wang; Shuhua Han; Jie Du; William E Mitch
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

Review 3.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

4.  MHC class II expression in pancreatic tumors: a link to intratumoral inflammation.

Authors:  Matthias M Gaida; Thilo Welsch; Esther Herpel; Darjus F Tschaharganeh; Lars Fischer; Peter Schirmacher; G Maria Hänsch; Frank Bergmann
Journal:  Virchows Arch       Date:  2011-11-27       Impact factor: 4.064

5.  TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.

Authors:  Frank Martiniuk; Diona L Damian; John F Thompson; Richard A Scolyer; Kam-Meng Tchou-Wong; William R Levis
Journal:  J Drugs Dermatol       Date:  2010-11       Impact factor: 2.114

6.  CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.

Authors:  Lian Ni Lee; Edward O Ronan; Catherine de Lara; Kees L M C Franken; Tom H M Ottenhoff; Elma Z Tchilian; Peter C L Beverley
Journal:  Infect Immun       Date:  2011-05-31       Impact factor: 3.441

7.  Expression analysis and clinical significance of CXCL16/CXCR6 in patients with bladder cancer.

Authors:  Jun Taik Lee; Sang Don Lee; Jeong Zoo Lee; Moon Kee Chung; Hong Koo Ha
Journal:  Oncol Lett       Date:  2012-10-17       Impact factor: 2.967

8.  Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer.

Authors:  Pranav Murthy; Mazen S Zenati; Amr I Al Abbas; Caroline J Rieser; Nathan Bahary; Michael T Lotze; Herbert J Zeh; Amer H Zureikat; Brian A Boone
Journal:  Ann Surg Oncol       Date:  2019-12-02       Impact factor: 5.344

9.  Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase.

Authors:  Thomas Grosse-Steffen; Thomas Giese; Nathalia Giese; Thomas Longerich; Peter Schirmacher; G Maria Hänsch; Matthias M Gaida
Journal:  Clin Dev Immunol       Date:  2012-11-20

10.  Increased serum CXCL16 is highly correlated with blood lipids, urine protein and immune reaction in children with active nephrotic syndrome.

Authors:  Junhui Zhen; Qian Li; Yanji Zhu; Xiujun Yao; Li Wang; Aihua Zhou; Shuzhen Sun
Journal:  Diagn Pathol       Date:  2014-01-24       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.